{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16132", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language without high-potency verbs, metaphors, or intensifiers.", "method": "llm_batch", "batch_id": "batch_2_18536", "batch_size": 200, "batch_pos": 53, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment refers to future manufacturing potential ('will be able to manufacture'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_16208", "batch_size": 200, "batch_pos": 190, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question designed to imply alarm.", "method": "llm_batch", "batch_id": "batch_4_13736", "batch_size": 200, "batch_pos": 184, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports uncertainty about manufacturing numbers; no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_1072", "batch_size": 200, "batch_pos": 179, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_8312", "batch_size": 200, "batch_pos": 124, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment contains 'too early to tell' which is not a bare negation of a risk or event.", "method": "llm_batch", "batch_id": "batch_7_17044", "batch_size": 200, "batch_pos": 94, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "Does not describe capability or preparedness measures.", "method": "llm_batch", "batch_id": "batch_8_6648", "batch_size": 200, "batch_pos": 111, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment reports it's too early to tell manufacturing numbers, not economic data or prices.", "method": "llm_batch", "batch_id": "batch_9_17352", "batch_size": 200, "batch_pos": 135, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states it is too early to tell about future manufacturing quantity, not speculating about relief or improvement.", "method": "llm_batch", "batch_id": "batch_10_12592", "batch_size": 200, "batch_pos": 2, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Contains attribution 'said Robert Johnson... on the call' but no direct quoted text.", "method": "llm_batch", "batch_id": "batch_11_20828", "batch_size": 200, "batch_pos": 198, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Factual report of status/limitation without explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_15368", "batch_size": 200, "batch_pos": 198, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
